These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Modulation of IgM anti-lymphocyte antibody-reactive T cell surface antigens in systemic lupus erythematosus. Winfield JB; Shaw M; Minota S J Immunol; 1986 May; 136(9):3246-53. PubMed ID: 3007614 [TBL] [Abstract][Full Text] [Related]
5. Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells. Sakane T; Steinberg AD; Reeves JP; Green I J Clin Invest; 1979 May; 63(5):954-65. PubMed ID: 312810 [TBL] [Abstract][Full Text] [Related]
6. A defect in the suppressor circuits among OKT4+ cell populations in patients with systemic lupus erythematosus occurs independently of a defect in the OKT8+ suppressor T cell function. Sakane T; Kotani H; Takada S; Murakawa Y; Ueda Y J Immunol; 1983 Aug; 131(2):753-61. PubMed ID: 6223093 [TBL] [Abstract][Full Text] [Related]
7. Fractionation of cells on a discontinuous Ficoll gradient. Study of subpopulations of human T cells using anti-T-cell antibodies from patients with systemic lupus erythematosus. Glinski W; Gershwin ME; Steinberg AD J Clin Invest; 1976 Mar; 57(3):604-14. PubMed ID: 55418 [TBL] [Abstract][Full Text] [Related]
8. Identification of three major target molecules of IgM antilymphocyte autoantibodies in systemic lupus erythematosus. Minota S; Winfield JB J Immunol; 1987 Dec; 139(11):3644-51. PubMed ID: 3500225 [TBL] [Abstract][Full Text] [Related]
9. Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction. Sagawa A; Abdou NI J Clin Invest; 1979 Mar; 63(3):536-9. PubMed ID: 311787 [TBL] [Abstract][Full Text] [Related]
10. Antibody to activated lymphocytes in patients with systemic lupus erythematosus. Kagami M; Koike T; Takabayashi K; Tomioka H; Yoshida S J Rheumatol; 1987 Oct; 14(5):907-12. PubMed ID: 3123675 [TBL] [Abstract][Full Text] [Related]
11. Activated T cells in human peripheral blood: quantitation with a reverse hemolytic plaque assay. Cohen PL; Litvin DA; Winfield JB J Immunol; 1981 Nov; 127(5):1777-81. PubMed ID: 7028863 [TBL] [Abstract][Full Text] [Related]
12. [Comparison between anti-lymphocyte antibodies in systemic lupus erythematosus and in Hodgkin's disease]. Del Giacco GS; Leone AL; Locci F; Manconi PE; Tognella S; Mantovani G; Grifoni V Boll Ist Sieroter Milan; 1976 Jul; 55(3):255-61. PubMed ID: 1087885 [TBL] [Abstract][Full Text] [Related]
13. Antibodies to T cells in patients with systemic lupus erythematosus can induce antibody-dependent cell-mediated cytotoxicity against human T cells. Kumagai S; Steinberg AD; Green I J Clin Invest; 1981 Mar; 67(3):605-14. PubMed ID: 6970750 [TBL] [Abstract][Full Text] [Related]
14. Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets. Sakane T; Steinberg AD; Reeves JP; Green I J Clin Invest; 1979 Nov; 64(5):1260-9. PubMed ID: 159312 [TBL] [Abstract][Full Text] [Related]
15. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus. Murakawa Y; Takada S; Ueda Y; Suzuki N; Hoshino T; Sakane T J Immunol; 1985 Jan; 134(1):187-95. PubMed ID: 3917275 [TBL] [Abstract][Full Text] [Related]
17. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production. Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187 [TBL] [Abstract][Full Text] [Related]
18. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052 [TBL] [Abstract][Full Text] [Related]
19. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Delgado Alves J; Kumar S; Isenberg DA Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551 [TBL] [Abstract][Full Text] [Related]
20. Anti-lymphocyte antibodies in systemic lupus erythematosus and in Hodgkin's disease: a comparison by immunofluorescence. Del Giacco GS; Leone AL; Locci F; Manconi PE; Tognella S; Mantovani G; Grifoni V Biomedicine; 1976 May; 25(3):79-80. PubMed ID: 779861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]